Article Information
History
- August 18, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Martina Patone, Statistician1,
- Andrew JHL Snelling, Senior Data Scientist1,
- Holly Tibble, Statistician3,
- Carol AC Coupland, Senior Researcher, Professor of Medical Statistics in Primary Care1,2,
- Aziz Sheikh, Professor of Primary Care Research and Development3 and
- Julia Hippisley-Cox, Professor of Clinical Epidemiology & General Practice1,*
- 1Nuffield Department of Primary Health Care Sciences, University of Oxford
- 2Usher Institute, University of Edinburgh
- 3Centre for Academic Primary Care, School of Medicine, University of Nottingham
- ↵*Correspondence to:
Professor Julia Hippisley-Cox, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, Woodstock Road, julia.hippisley-cox{at}phc.ox.ac.uk
Posted August 18, 2022.
Uptake of Sotrovimab for prevention of severe COVID-19 and its safety in the community in England
